These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 25378951)

  • 1. Systemic AA amyloidosis: epidemiology, diagnosis, and management.
    Real de Asúa D; Costa R; Galván JM; Filigheddu MT; Trujillo D; Cadiñanos J
    Clin Epidemiol; 2014; 6():369-77. PubMed ID: 25378951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Al amyloidosis.
    Desport E; Bridoux F; Sirac C; Delbes S; Bender S; Fernandez B; Quellard N; Lacombe C; Goujon JM; Lavergne D; Abraham J; Touchard G; Fermand JP; Jaccard A;
    Orphanet J Rare Dis; 2012 Aug; 7():54. PubMed ID: 22909024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prevalence and Management of Systemic Amyloidosis in Western Countries.
    Nienhuis HL; Bijzet J; Hazenberg BP
    Kidney Dis (Basel); 2016 Apr; 2(1):10-9. PubMed ID: 27536687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic AA amyloidosis induced by benign neoplasms].
    Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
    Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Method of DAPI Staining for Differential Diagnosis of Renal Amyloidosis.
    Matsuura M; Abe H; Tominaga T; Sakurai A; Murakami T; Kishi S; Bando Y; Minakuchi J; Nagai K; Doi T
    J Med Invest; 2017; 64(3.4):217-221. PubMed ID: 28954985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Amyloidosis: A Clinicopathological Study From a Tertiary Care Hospital in Pakistan.
    Ahmed S; Nasir H; Moatasim A; Khalil F
    Cureus; 2022 Jan; 14(1):e21122. PubMed ID: 35165578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic studies with iodine-123-labeled serum amyloid P component in patients with systemic AA and AL amyloidosis and assessment of clinical value.
    Jager PL; Hazenberg BP; Franssen EJ; Limburg PC; van Rijswijk MH; Piers DA
    J Nucl Med; 1998 Apr; 39(4):699-706. PubMed ID: 9544684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological evaluation of the distribution of systemic AA-amyloidosis in nine domestic shorthair cats.
    Moccia V; Vogt AC; Ricagno S; Callegari C; Vogel M; Zini E; Ferro S
    PLoS One; 2023; 18(11):e0293892. PubMed ID: 37917747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significant association between renal function and area of amyloid deposition in kidney biopsy specimens in both AA amyloidosis associated with rheumatoid arthritis and AL amyloidosis.
    Kuroda T; Tanabe N; Hasegawa E; Wakamatsu A; Nozawa Y; Sato H; Nakatsue T; Wada Y; Ito Y; Imai N; Ueno M; Nakano M; Narita I
    Amyloid; 2017 Jun; 24(2):123-130. PubMed ID: 28613962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of amyloidosis.
    Tan SY; Pepys MB; Hawkins PN
    Am J Kidney Dis; 1995 Aug; 26(2):267-85. PubMed ID: 7645531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histochemical and immunohistochemical differential diagnosis of amyloidosis--a brief illustrated essay and personal experience with Romhányi's method.
    Bély M; Apáthy A
    Amyloid; 2000 Sep; 7(3):212-7. PubMed ID: 11019862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and therapeutic approach of systemic amyloidosis.
    Hazenberg BP; van Gameren II; Bijzet J; Jager PL; van Rijswijk MH
    Neth J Med; 2004 Apr; 62(4):121-8. PubMed ID: 15255082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histopathological diagnosis of amyloidosis].
    Hoshii Y
    Rinsho Byori; 2006 May; 54(5):513-8. PubMed ID: 16789423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
    Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein.
    Gillmore JD; Lovat LB; Persey MR; Pepys MB; Hawkins PN
    Lancet; 2001 Jul; 358(9275):24-9. PubMed ID: 11454373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid.
    Sjölander D; Röcken C; Westermark P; Westermark GT; Nilsson KP; Hammarström P
    Amyloid; 2016 Jun; 23(2):98-108. PubMed ID: 26987044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of eprodisate for the treatment of renal disease in AA amyloidosis.
    Rumjon A; Coats T; Javaid MM
    Int J Nephrol Renovasc Dis; 2012; 5():37-43. PubMed ID: 22427728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pathology of Amyloidosis in Classification: A Review.
    Picken MM
    Acta Haematol; 2020; 143(4):322-334. PubMed ID: 32392555
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.